Author:
Arriola Edurne,Marchio Caterina,Tan David SP,Drury Suzanne C,Lambros Maryou B,Natrajan Rachael,Rodriguez-Pinilla Socorro Maria,Mackay Alan,Tamber Narinder,Fenwick Kerry,Jones Chris,Dowsett Mitch,Ashworth Alan,Reis-Filho Jorge S
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Pathology and Forensic Medicine
Reference47 articles.
1. Jonkers J, Berns A . Oncogene addiction: sometimes a temporary slavery. Cancer Cell 2004;6:535–538.
2. Baselga J, Tripathy D, Mendelsohn J, et al. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol 1999;26:78–83.
3. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659–1672.
4. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353:1673–1684.
5. Muss HB, Thor AD, Berry DA, et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260–1266.
Cited by
124 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献